Ethical Sourcing and Rigorous Screening
Umbilical cord stem cells are harvested from umbilical cords donated by mothers who have undergone full-term C-section births. These donations are entirely voluntary, with mothers providing informed consent.
During the collection process, the donated tissue undergoes rigorous screening and testing for genetic and infectious diseases. The Food and Drug Administration (FDA) oversees all public cord blood banks, ensuring that only the highest quality, uncontaminated and healthy cells are used.
After rigorous screening, Wharton’s jelly, the stem cell-rich tissue surrounding umbilical cord blood vessels, is isolated from other components such as red blood cells. Special techniques then extract and expand these stem cells. Finally, they’re formulated into a safe injectable solution.
The cells collected for stem cell transplants or injections are known as mesenchymal stem cells. They’re highly sought after because they can transform into many specialized cells and have the potential to promote healing and regeneration.